Cystic Fibrosis News

UNC researchers have identified genetic pathways that play major roles in the severity of cystic fibrosis.
A chemical known as allicin that is found in garlic can kill bacteria that cause life-threatening lung infections in people with cystic fibrosis, research suggests.
Researchers are recruiting participants for a clinical trial designed to assess the sensation of shortness of breath (dyspnea) in patients with cystic fibrosis during exercise.
Arkansas Medicaid has settled a federal lawsuit brought by patients denied the cystic fibrosis (CF) drug Kalydeco due its high cost.
Celtaxsys, Inc, a clinical stage biotechnology company, announced that the FDA has granted orphan drug designation to its cystic fibrosis treatment drug leukotriene A4 hydrolase inhibitor.
During the recent state of the union address, President Obama highlighted cystic fibrosis as a model for the government's strategy for precision medicine and treatment.
Shire has just announced a new partnership with the Cystic Fibrosis Foundation to develop technology that can maintain lung function and protect against respiratory infections.
PulmoFlow Inc's Kitabis Pak, a co-packaging of generic tobramycin inhalation solution with a PARI LC PLUS Nebulizer, has been approved to treat cystic fibrosis.
Gone are the days when an RT had to use muscle alone to clear lung secretions. Technology has made this more efficient, effective, and patient friendly.
Researchers have shown for the first time how bacteria can grow directly in the lungs of cystic fibrosis patients, which has provided tremendous insights into bacteria behavior and growth in chronic infections.
Researchers have discovered an inhibitor for an enzyme called Sphingomyelin phosphodiesterase C (SMaseC) which is produced by the S. aureus bacterium and may harm the health of CF patients.
A team of international researchers found that the immunological cell surface molecule HLA-DQ is reduced or absent in many cystic fibrosis patients.
Scientists now have shown that many of the adult patients with cystic fibrosis in addition lack a cell surface molecule, important for immune defence.
Researchers hope the drug sildenafil, as well as a cocktail of over-the-counter antioxidants, will help them identify the root of the blood vessel dysfunction that makes exercise difficult for CF patients.
New research shows that cystic fibrosis causes a specific defect in the lungs' mucus process.
Vertex Pharmaceuticals Inc says results from two Phase 3 studies of its lumacaftor-ivacaftor drug combination showed statistically significant improvements in lung function (ppFEV1) in cystic fibrosis patients (12+) who have two copies of the F508del mutation.
OligoG, a breakthrough medication derived from Norwegian seaweed, may be an effective treatment for cystic fibrosis, according to research that suggests it helps to break down the thick, sticky mucus that characterizes CF.
As the number of chronic lung patients continues to grow, today’s aerosol therapy products are providing high-quality, cost-efficient medication delivery.
Boosting a key immune process called autophagy with interferon gamma (IFN-γ) could help clear a lethal bacterial infection in cystic fibrosis, a new study suggests.
Electromed Inc has joined in the launch of a new children’s book, Healthy Choices, Happy Kids: Making Good Choices with Everyday Care, and will include a free copy of the book with all SmartVest shipments for newly prescribed patients 10 years old and younger (while supplies last).